New weapons to snuff out kidney cancer.
Learn how to assess and care for a patient with this often-hidden cancer. Then get the scoop on two newly approved drugs to treat advanced stages of the disease.
Wetherbee
Sandra L
SL
Fox Chase Cancer Center, Philadelphia, PA, USA.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001557:Benzenesulfonates / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000451:nursing / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy / Q000451:nursing*; D007211:Indoles / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000451:nursing / Q000628:therapy*; D009392:Nephrectomy / Q000451:nursing*; D009536:Niacinamide / Q000031:analogs & derivatives; D010671:Phenylurea Compounds; D011182:Postoperative Care; D011725:Pyridines / Q000627:therapeutic use; D011758:Pyrroles / Q000627:therapeutic use; D000077157:Sorafenib; D000077210:Sunitinib
D000970:Antineoplastic Agents; D001557:Benzenesulfonates; D007211:Indoles; D010671:Phenylurea Compounds; D011725:Pyridines; D011758:Pyrroles; D009536:Niacinamide; D000077157:Sorafenib; D000077210:Sunitinib